| All Releases |
 |
Biodel Reports First Quarter Fiscal Year 2010 Financial Results
Feb 4, 2010
|
18.8 KB |
|
| |
DANBURY, Conn., Feb 04, 2010 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for the
first fiscal quarter ended December 31, 2009.
First Quarter Financial Results
Biodel reported a net loss for the quarter ended December 31, 2009 of
$11.1 million, or $0.47 per share, compared to a net loss of $10.0
...
|
|
Biodel to Report First Quarter Fiscal Year 2010 Financial Results on February 4, 2010
Feb 1, 2010
|
8.9 KB |
|
| |
DANBURY, Conn., Feb 01, 2010 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) will issue its first quarter fiscal year 2010
financial results on February 4, 2010. Following the release of the
company's financial results, Biodel's senior management will host a
conference call to discuss the results and provide an update on the
...
|
|
Biodel Inc. to Present at 28th Annual JPMorgan Healthcare Conference on January 14th, 2010
Jan 6, 2010
|
7.7 KB |
|
| |
DANBURY, Conn., Jan 06, 2010 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner,
Chairman and CEO of Biodel, will present a corporate update at the 28th
Annual JPMorgan Healthcare Conference on Thursday, January 14, 2010 at
8:30 a.m. Pacific Time.
The JPMorgan Healthcare Conference will b...
|
|
Biodel Submits VIAject(R) New Drug Application to FDA for Treatment of Diabetes
Dec 30, 2009
|
12.0 KB |
|
| |
DANBURY, Conn., Dec 30, 2009 (BUSINESS WIRE) -- Biodel, Inc. (Nasdaq: BIOD) announced today that it has submitted a new
drug application (NDA) to the U.S. Food and Drug Administration for
clearance to market VIAject(R) as a treatment for diabetes. VIAject(R) is
Biodel's proprietary formulation of recombinant human insulin th...
|
|
Biodel Reports Fourth Quarter and Fiscal Year 2009 Financial Results
Dec 10, 2009
|
20.7 KB |
|
| |
DANBURY, Conn., Dec 10, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for the
fourth quarter and fiscal year ended September 30, 2009.
Fourth Quarter and Fiscal Year 2009
Financial ResultsBiodel reported a net loss for the quarter ended September 30, 2009 of
$10.5 million, or $0.44 per ...
|
|
Biodel to Report Fourth Quarter and Fiscal Year 2009 Financial Results on December 10, 2009
Dec 7, 2009
|
8.1 KB |
|
| |
DANBURY, Conn., Dec 07, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) will issue its fourth quarter and fiscal year
2009 financial results on December 10, 2009. Following the release of
the company's financial results, Biodel's senior management will host a
conference call to discuss the results and provide an update on...
|
|
Biodel Inc. to Present at Oppenheimer 20th Annual Healthcare Conference on November 3rd, 2009
Oct 30, 2009
|
9.4 KB |
|
| |
DANBURY, Conn., Oct 30, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner,
Chairman and CEO of Biodel, will present a corporate update at the
Oppenheimer 20th Annual Healthcare Conference on November 3rd, 2009 at
9:40 am Atlantic Time.
Interested parties may access the presentation ...
|
|
Biodel Inc. to Present at Morgan Stanley 2009 Global Healthcare Unplugged Conference on September 14th, 2009
Sep 11, 2009
|
9.4 KB |
|
| |
DANBURY, Conn., Sep 11, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner,
Chairman and CEO of Biodel, will present a corporate update at the
Morgan Stanley 2009 Global Healthcare Unplugged Conference in New York
on Monday, September 14, 2009 at 4:30 pm Atlantic Time.
Interested par...
|
|
Biodel Reports Third Quarter Fiscal Year 2009 Financial Results
Aug 7, 2009
|
18.1 KB |
|
| |
DANBURY, Conn., Aug 07, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for the
third quarter ended June 30, 2009.
Third Quarter Fiscal Year 2009 Financial
ResultsBiodel reported a net loss for the quarter ended June 30, 2009 of $11.1
million, or $0.47 per share, compared to a net loss of...
|
|
Biodel to Report Third Quarter Fiscal Year 2009 Results on August 7, 2009
Aug 3, 2009
|
8.0 KB |
|
| |
DANBURY, Conn., Aug 03, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) will issue its fiscal third quarter 2009
financial results on August 7, 2009. Following the release of the
company's financial results, Biodel's senior management will host a
conference call to discuss the results and provide an update on the
...
|
|
Biodel Inc. to Present at 8th Annual Needham & Company Life SciencesConference on June 11th, 2009
Jun 9, 2009
|
9.4 KB |
|
| |
DANBURY, Conn., Jun 09, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner,
Chairman and CEO of Biodel, will present a corporate update at the
Needham & Company's Eighth Annual Life Sciences Conference at the New
York Palace Hotel on June 11, 2009 at 3:00 p.m. Atlantic Time.
Interest...
|
|
VIAject(R) Presentations at ADA Meeting Highlight Drug's Mechanism of Absorption and Microvascular Effects
Jun 8, 2009
|
12.0 KB |
|
| |
DANBURY, Conn., Jun 08, 2009 (BUSINESS WIRE) -- Biodel, Inc. (Nasdaq:BIOD) today reported new information regarding the
mechanism of action of VIAject(R) (injectable prandial insulin) and an
update on previously reported findings regarding the effects of VIAject(R)
on microvascular function in patients with type 2 diabetes. ...
|
|
Biodel Inc. Reports Second Quarter Fiscal Year 2009 Financial Results
May 7, 2009
|
16.8 KB |
|
| |
DANBURY, Conn., May 07, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for the
second quarter ended March 31, 2009 and provided an update on recent
progress with its lead product candidate, VIAject(R).
Second Quarter Fiscal Year 2009
Financial ResultsBiodel reported a net loss for the qu...
|
|
Biodel to Report Second Quarter Fiscal Year 2009 Results on May 7, 2009
May 4, 2009
|
8.0 KB |
|
| |
DANBURY, Conn., May 04, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) will issue its fiscal second quarter 2009
financial results on May 7, 2009. Following the release of the company's
financial results, Biodel's senior management will host a conference
call to discuss the results and provide an update on the company's ...
|
|
Biodel to Submit New Drug Application for VIAject(R) to FDA
Mar 24, 2009
|
12.4 KB |
|
| |
DANBURY, Conn., Mar 24, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) announced today its plan to submit a new drug
application (NDA) to the U.S. Food and Drug Administration (FDA) in the
second half of this year for approval to market VIAject(R) for the
treatment of diabetes. VIAject(R) is Biodel's investigational
...
|
|
Biodel Reports First Quarter Fiscal Year 2009 Financial Results and Clinical Update
Feb 5, 2009
|
17.3 KB |
|
| |
DANBURY, Conn., Feb 05, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for the
first quarter ended December 31, 2008 and provided an update on recent
clinical findings with its lead product candidate, VIAject(TM).
First Quarter Fiscal Year 2009 Financial
ResultsBiodel reported a net loss...
|
|
Biodel to Report First Quarter Fiscal Year 2009 Results and Top Line Results of Bioequivalence Study on February 5, 2009
Jan 30, 2009
|
8.2 KB |
|
| |
DANBURY, Conn., Jan 30, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) will issue its fiscal first quarter 2009
financial results on February 5, 2009. The company will also discuss the
top line results of its study testing the bioequivalence of the 25 IU
two part formulation and 100 IU one part liquid formulation of
...
|
|
Biodel Inc. to Present at 27th Annual JPMorgan Healthcare Conference on January 15th, 2009
Jan 9, 2009
|
7.7 KB |
|
| |
DANBURY, Conn., Jan 09, 2009 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner,
Chairman and CEO of Biodel, will present a corporate update at the 27th
Annual JPMorgan Healthcare Conference on Thursday, January 15, 2009 at
8:30 a.m. Pacific Time.
The JPMorgan Healthcare Conference will b...
|
|
Biodel Inc. Reports Fourth Quarter and Fiscal Year 2008 Financial Results
Dec 10, 2008
|
18.7 KB |
|
| |
DANBURY, Conn., Dec 10, 2008 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for the
fourth quarter and fiscal year ended September 30, 2008 and reviewed
recent corporate activities and plans.
Fourth Quarter and Full Year 2008
Financial ResultsBiodel reported a net loss for the fourth quarter ...
|
|
Biodel to Report Fourth Quarter and Fiscal Year 2008 Financial Results on December 10, 2008
Dec 2, 2008
|
8.1 KB |
|
| |
DANBURY, Conn., Dec 02, 2008 (BUSINESS WIRE) -- Biodel Inc. (Nasdaq: BIOD) will issue its fourth quarter and fiscal year
2008 financial results on December 10, 2008. Following the release of
the company's financial results, Biodel's senior management will host a
conference call to discuss the results and provide an update on...
|
|
|
